Search Results - "Girnius, S."
-
1
Autologous hematopoietic cell transplantation for multiple myeloma patients with renal insufficiency: a center for international blood and marrow transplant research analysis
Published in Bone marrow transplantation (Basingstoke) (01-12-2017)“…Autologous hematopoietic cell transplantation (AHCT) in multiple myeloma (MM) patients with renal insufficiency (RI) is controversial. Patients who underwent…”
Get full text
Journal Article -
2
Safety and efficacy of high-dose melphalan and auto-SCT in patients with AL amyloidosis and cardiac involvement
Published in Bone marrow transplantation (Basingstoke) (01-03-2014)“…In Ig light chain (AL) amyloidosis, cardiac involvement is associated with worse prognosis and increased treatment-related complications. In this retrospective…”
Get full text
Journal Article -
3
-
4
-
5
The changing face of AA amyloidosis: a single center experience
Published in Amyloid (01-06-2011)Get full text
Journal Article -
6
Cancer-testis antigen expression and immunogenicity in AL amyloidosis
Published in Blood cancer journal (New York) (01-09-2012)“…Light-chain amyloidosis (AL) is a plasma cell dyscrasia closely related to multiple myeloma. In multiple myeloma, the cancer-testis antigens (CTAs) CT7…”
Get full text
Journal Article -
7
High-dose melphalan and autologous stem cell transplantation for AL amyloidosis: recent trends in treatment-related mortality and 1-year survival at a single institution
Published in Amyloid (01-06-2011)“…Treatment with high-dose melphalan chemotherapy supported by hematopoietic rescue with autologous stem cells produces high rates of hematologic responses and…”
Get full text
Journal Article -
8
Challenges in multiple myeloma diagnosis and treatment
Published in Leukemia (01-05-2013)“…Although multiple myeloma (MM) remains an incurable disease, the advent of novel treatment paradigms has improved survival outcomes in the past two decades…”
Get full text
Journal Article -
9
Hematopoietic cell transplantation utilization and outcomes for primary plasma cell leukemia in the current era
Published in Leukemia (01-12-2020)“…The outcomes of patients with primary plasma cell leukemia (pPCL) after undergoing hematopoietic cell transplantation (HCT) in the novel agent era are unknown…”
Get full text
Journal Article -
10
-
11
Challenges in multiple myeloma diagnosis and treatment
Published in Leukemia supplements (01-05-2013)“…Although multiple myeloma (MM) remains an incurable disease, the advent of novel treatment paradigms has improved survival outcomes in the past two decades…”
Get full text
Journal Article -
12
Hepatic response after high-dose melphalan and stem cell transplantation in patients with AL amyloidosis associated liver disease
Published in Haematologica (Roma) (01-07-2009)“…1 Department of Medicine 2 Stem Cell Transplantation Program of the Section of Hematology-Oncology and 3 Amyloid Treatment and Research Program, Department of…”
Get full text
Journal Article -
13
Hispanics have the lowest stem cell transplant utilization rate for autologous hematopoietic cell transplantation for multiple myeloma in the United States: A CIBMTR report
Published in Cancer (15-08-2017)“…BACKGROUND Race/ethnicity remains an important barrier in clinical care. The authors investigated differences in the receipt of autologous hematopoietic cell…”
Get full text
Journal Article -
14
Support of trigeminal sensory neurons by nonneuronal p75 neurotrophin receptors
Published in Brain research. Developmental brain research (19-05-2004)“…The p75 neurotrophin receptor (p75NTR) binds all four mammalian neurotrophins, including neurotrophin-3 (NT-3) required for the development of select sensory…”
Get full text
Journal Article -
15